TELMISARTAN MARKET ANALYSIS

Market Concentration and Competitive Landscape

Close-monitor your Competitor's Move, Request sample copy

Growing awareness about telmisartan therapy

Global telmisartan market growth is driven by growing awareness about its effectiveness and safety in the treatment of hypertension. Telmisartan is an angiotensin receptor blocker (ARB) that is widely prescribed by cardiologists and vascular physicians for management of high blood pressure. It is known to be well-tolerated with minimal side effects as compared to other anti-hypertensive drugs. For instance, as per the report published by the American Heart Association in 2021, long term use of telmisartan lowered the risk of stroke and dementia in elderly hypertensive patients. As per a meta-analysis published by European Journal of Preventive Cardiology in 2020, telmisartan is superior over other ARBs in reducing cardiovascular and all-cause mortality. Growing evidence of telmisartan's organ protective qualities beyond blood pressure control has increased physician's preference for the drug. Telmisartan has also gained traction due to its affordability and once-daily dosing regimen. This ensures high patient compliance which is crucial for effective management of lifelong conditions like hypertension. According to the data from World Health Organization in 2022, non-adherence to medication is a major public health challenge especially in developing nations. The simplicity and low cost of telmisartan therapy makes it suitable for improving access and adherence to treatment in resource-constrained settings.